Pacira BioSciences Inc.

PCRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$24.96

+$0.85 (+3.53%)

Sep 22, 2026, 1:03 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	726.41M	700.97M	674.98M	666.82M	541.53M	429.65M
Cost of Revenue	149.75M	170.43M	184.67M	199.3M	140.26M	117.33M
Gross Profit	576.66M	530.54M	490.31M	467.53M	401.28M	312.32M
Operating Income	33.3M	-73.37M	87.68M	60.02M	89.92M	46.35M
Interest Income	22.73M	19.69M	11.44M	4.54M	896K	4.63M
Pretax Income	16.87M	-63.11M	61.7M	13.3M	56.4M	20.09M
Net Income	7.03M	-99.56M	41.96M	15.91M	41.98M	145.52M
Selling & General & Admin	368.76M	294.1M	269.44M	254.52M	199.35M	193.52M
Research & Development	117.31M	81.58M	76.26M	84.8M	55.55M	59.42M
Other Expenses	57.29M	228.23M	56.94M	68.19M	56.46M	13.03M
Operating Expenses	543.36M	603.91M	402.63M	407.5M	311.35M	265.97M
Interest Expense	14.61M	16.57M	17.31M	35.58M	29M	25.67M
Selling & Marketing Expenses	226.62M	172.02M	153.04M	145M	111.02M	118.68M
Cost & Expenses	693.11M	774.34M	587.3M	606.8M	451.61M	383.3M
Income Tax Expense	9.84M	36.45M	19.75M	-2.61M	14.42M	-125.43M
Shares Outstanding (Basic)	44.57M	46.25M	46.22M	45.52M	44.26M	42.67M
Shares Outstanding (Diluted)	45.04M	46.25M	51.98M	46.54M	45.63M	43.68M
EPS (Basic)	0.16	-2.15	0.91	0.35	0.95	3.41
EPS (Diluted)	0.16	-2.15	0.89	0.34	0.92	3.33
EBITDA	122.5M	29.12M	154.59M	140.38M	113.95M	63.51M
EBIT	31.48M	-49.67M	79.01M	48.88M	85.4M	43.6M
Depreciation & Amortization	91.02M	78.79M	75.57M	91.5M	28.55M	19.91M